Look for:

Our offer for

BIOMARIN PHARMACEUTICAL INC.


ISIN:
US09061G1013
WKN:
09061G101

2024/03/28 14:50:37
Price
81.80 EUR
Difference -0.07% (-0.06)

General attributes

ISINUS09061G1013
SymbolBMRN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)15,463 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)80.94 EUR (250)
Ask (Ask size)80.96 EUR (250)
Open81.98 EUR
High81.98 EUR
Low81.80 EUR
Close (prev. day)81.86 EUR
VWAP81.89351 EUR
Volume (pcs)191
Trading volume15,641.66
Number of trades4
Last size54

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOMARIN PHARMACEUTICAL INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 14:50:37
Price
81.80 EUR
Difference -0.07% (-0.06)

General attributes

ISINUS09061G1013
SymbolBMRN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)15,463 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)80.94 EUR (250)
Ask (Ask size)80.96 EUR (250)
Open81.98 EUR
High81.98 EUR
Low81.80 EUR
Close (prev. day)81.86 EUR
VWAP81.89351 EUR
Volume (pcs)191
Trading volume15,641.66
Number of trades4
Last size54

Performance and Risk

6m1Y3Y
Perf (%)-4.86%-3.43%+27.99%
Perf (abs.)-4.18-2.91+17.90
Beta0.650.580.73
Volatility27.9126.4230.41
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)79.75 EUR (185)
Ø price 30 days | Ø volume 30 days (pcs.)80.14 EUR (115)
Ø price 100 days | Ø volume 100 days (pcs.)82.95 EUR (64)
Ø price 250 days | Ø volume 250 days (pcs.)83.13 EUR (77)
YTD High | date90.36 EUR (2024/01/08)
YTD Low | date76.88 EUR (2024/03/19)
52 Weeks High | date91.76 EUR (2023/04/17)
52 Weeks Low | date71.16 EUR (2023/11/06)

All listings for BIOMARIN PHARMACEUTICAL INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/11/2417:3581.02 EUR0.002
Vienna Stock Exchange2024/03/2817:3281.46 EUR0.003
Tradegate2024/03/2814:5081.80 EUR0.024
Stuttgart2024/03/2815:3081.44 EUR0.002
Nasdaq2024/03/2820:3987.20 USD49.1012,761
Munich2024/03/2808:0581.70 EUR0.001
London Stock Exchange2023/12/0515:3094.23 USD0.001
Hanover2024/03/2808:1081.68 EUR0.001
Frankfurt2024/03/2808:0181.66 EUR0.001
Euronext Milan MTF Trading After Hours---0.00-
Euronext Milan MTF Global Equity Market2024/03/2817:4481.76 EUR0.001
Duesseldorf2024/03/2819:3180.44 EUR0.005
Berlin2024/03/2808:0881.66 EUR0.001
BX Swiss2024/02/0718:0078.661 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=585&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOMARIN PHARMACEUTICAL INC.
- -
770 Lindaro Street - 94901 San Rafael
Telefon: +1-415-506-6700
Fax: +1-415-382-7889
E-mail: customersupport@bmrn.com

PDF Downloads

Company report: BIOMARIN PHARMACEUTICAL INC.PDF Download

Company Profile

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Members of Management Board

Richard MeierChairman of Board of Directors
Athena CountouriotisMember of Board of Directors
Dennis SlamonMember of Board of Directors
Elaine HeronMember of Board of Directors
May Kin HoMember of Board of Directors
V. LawlisMember of Board of Directors
Willard DereMember of Board of Directors
Barbara BodemMember of Board of Directors
David PyottMember of Board of Directors
Elizabeth AndersonMember of Board of Directors
Jean-Jacques BienaiméMember of Board of Directors
Mark AllesMember of Board of Directors
Mark EnyedyMember of Board of Directors
Robert HombachMember of Board of Directors
Jean-Jacques BienaiméChairman of Managing Board
Brinda BalakrishnanMember of Executive Committee
C. Greg GuyerMember of Executive Committee
Amy WiremanMember of Executive Committee
Brian MuellerMember of Executive Committee
G. Eric DavisMember of Executive Committee
Henry J. FuchsMember of Executive Committee
Jeff AjerMember of Executive Committee
Philip Lo ScalzoMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer